Perspective Therapeutics (CATX) Insider Trading & Ownership → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free CATX Stock Alerts $1.38 +0.06 (+4.55%) (As of 05/31/2024 08:50 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Perspective Therapeutics (NYSE:CATX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.52%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$57.70 MNumber OfInsiders Selling(Last 12 Months)0 Get CATX Insider Trade Alerts Want to know when executives and insiders are buying or selling Perspective Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CATX Insider Buying and Selling by Quarter Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Perspective Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/29/2024Robert F Williamson IIIDirectorBuy30,031$1.33$39,941.23 3/6/2024Lantheus Alpha Therapy, LlcMajor ShareholderBuy60,431,039$0.95$57,409,487.05 1/29/2024Robert F Williamson IIIDirectorBuy25,266$0.64$16,170.24 1/25/2024Robert F Williamson IIIDirectorBuy22,134$0.49$10,845.66 1/24/2024Markus PuhlmannInsiderBuy280,000$0.50$140,000.00 12/21/2023Robert F Williamson IIIDirectorBuy3,663$0.33$1,208.79 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/18/2023Jonathan Robert HuntCFOBuy125,000$0.26$32,500.00 12/18/2023Markus PuhlmannInsiderBuy60,419$0.26$15,708.94 12/18/2023Robert F Williamson IIIDirectorBuy10,000$0.26$2,600.00 12/15/2023Markus PuhlmannInsiderBuy135,006$0.27$36,451.62 (Data available from 1/1/2013 forward) CATX Insider Trading Activity - Frequently Asked Questions Who is on Perspective Therapeutics's Insider Roster? The list of insiders at Perspective Therapeutics includes Jonathan Robert Hunt, Lantheus Alpha Therapy, Llc, Markus Puhlmann, and Robert F Williamson III. Learn more on insiders at CATX. What percentage of Perspective Therapeutics stock is owned by insiders? 3.52% of Perspective Therapeutics stock is owned by insiders. Learn more on CATX's insider holdings. Which Perspective Therapeutics insiders have been buying company stock? The following insiders have purchased CATX shares in the last 24 months: Jonathan Robert Hunt ($32,500.00), Lantheus Alpha Therapy, Llc ($57,409,487.05), Markus Puhlmann ($192,160.56), and Robert F Williamson III ($70,765.92). How much insider buying is happening at Perspective Therapeutics? Insiders have purchased a total of 61,122,558 CATX shares in the last 24 months for a total of $57,704,913.53 bought. More Insider Trading Tools from MarketBeat Related Companies: AXNX Insider Selling PRCT Insider Selling TNDM Insider Selling NARI Insider Selling IRTC Insider Selling ICUI Insider Selling IART Insider Selling NVCR Insider Selling UFPT Insider Selling LMAT Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month This page (NYSE:CATX) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden Nomination CANCELED?The Freeport SocietyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTradeShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBill Gates is all about this tiny $2 stockTimothy SykesBiden replacement revealed?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Perspective Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.